Compass Wealth Management LLC Makes New $1.17 Million Investment in SPDR S&P Biotech ETF $XBI

Compass Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 11,499 shares of the exchange traded fund’s stock, valued at approximately $1,167,000.

Other institutional investors have also modified their holdings of the company. Ameriprise Financial Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares during the period. Meitav Investment House Ltd. lifted its stake in shares of SPDR S&P Biotech ETF by 2,199.6% in the 2nd quarter. Meitav Investment House Ltd. now owns 400,454 shares of the exchange traded fund’s stock worth $33,229,000 after acquiring an additional 383,040 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of SPDR S&P Biotech ETF by 2.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 10,638,105 shares of the exchange traded fund’s stock worth $882,218,000 after acquiring an additional 268,399 shares during the period. Marshall Wace LLP boosted its holdings in shares of SPDR S&P Biotech ETF by 102.3% in the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after acquiring an additional 179,029 shares in the last quarter. Finally, Clal Insurance Enterprises Holdings Ltd increased its stake in shares of SPDR S&P Biotech ETF by 68.5% during the second quarter. Clal Insurance Enterprises Holdings Ltd now owns 428,000 shares of the exchange traded fund’s stock worth $35,494,000 after acquiring an additional 174,000 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.1%

NYSEARCA XBI opened at $127.86 on Tuesday. The stock has a market capitalization of $8.56 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09. The firm has a 50-day moving average price of $122.86 and a 200 day moving average price of $106.29.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.